Yd Bio LTD

Kochi Chang, a Director of YD Bio Ltd, reported multiple transactions in common stock on September 30, 2026.

Shao-Ta Lu, a Director of YD Bio Ltd, reported multiple transactions in common stock on September 30, 2026.

Ethan Shen, CEO and a Director of YD Bio Ltd, purchased 12,700 shares of common stock on September 14, 2026 for $3.85 per share.

Ethan Shen, CEO and a Director of YD Bio Ltd, purchased 3,100 shares of common stock on September 9, 2026 for $3.93 per share.

Ethan Shen, CEO and a Director of YD Bio Ltd, purchased 18,378 shares of common stock on September 4, 2026 for $3.67 per share.

YD Bio Ltd. Director Lu Shao-Ta reported the acquisition of 5,749 ordinary shares through restricted stock units on June 30, 2026.

Ethan Shen and his affiliated entities have reported beneficial ownership of 77.1% of YD Bio Ltd's ordinary shares as of September 30, 2025.